LV Longevity Lab expands regenerative treatment options as interest grows in non-surgical knee osteoarthritis care LAS ...
INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...
Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...
French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ...
A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, nontender, nonbleeding cutaneous papule with an erythematous rim on the left thigh. Her parents ...
ROME, May 29 (Reuters) - The European Central Bank will act in a "timely and measured manner" to prevent the current energy shock ‌from turning into persistent inflation, governing council member ...
TOKYO, May 28 (Reuters) - The energy shock caused by the Middle East conflict will likely have a persistent impact on inflation even if there is a quick solution to the war, ‌the European Central Bank ...
Concerns about the president's health have intensified since the beginning of his second term -Credit:KENT NISHIMURA, AFP via Getty Images President Donald Trump visited Walter Reed National Military ...
PHILADELPHIA (WPVI) -- Chronic wounds are a major challenge in medicine. They quadruple the chances of dying within the next year. But doctors do have many tools now to save lives. For years, Sherman ...
Editor’s Note: This article contains frank descriptions of battlefield conditions, including accounts of soldiers dying by suicide following injury. These assumptions no longer hold. Drawing on my ...
Cloud-native, or containerised, applications are now mainstream. As many as 82% of enterprises now have Kubernetes in production, according to the Cloud Native Computing Forum (CNCF). That is up from ...
Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is unclear.